Obiettivo We will develop gene therapy approaches for wiskott-Aldrich syndrome, based on ex vivo transduction of T lymphocytes or hematopoietic progenitors with retroviral vectors. Efficacy and safety will be assessed in preclinical studies. Campo scientifico medical and health sciencesmedical biotechnologygenetic engineeringgene therapy Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-2. - Key action Control of Infectious Diseases Invito a presentare proposte Data not available Meccanismo di finanziamento RGI - Research grants (individual fellowships) Coordinatore FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO Contributo UE Nessun dato Indirizzo Via Olgettina 58 20132 MILANO Italia Mostra sulla mappa Costo totale Nessun dato